|
Cours en clôture
02/09/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
8,600 CNY
|
-1,83%
|
 |
-11,43%
|
+8,31%
|
|
25/08 |
Beijing Beilu Pharmaceutical Co., Ltd. Proposes Interim Cash Dividend for 2026
| | |
24/08 |
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
| | |
28/04 |
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
27/04 |
Beijing Beilu Pharmaceutical Co., Ltd. announced that it has received CNY 159 million in funding from a group of investors
| | |
21/04 |
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
| | |
28/10/25 |
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
03/09/25 |
Beijing Beilu Pharmaceutical Subsidiary Gets License to Enter Brazilian Market
| | |
25/08/25 |
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
22/07/25 |
Beijing Beilu Pharmaceutical Gets India Nod for Angiogram Constrasting Agent
| | |
10/06/25 |
Beijing Beilu Pharmaceutical Co., Ltd Announces Executive Changes
| | |
09/05/25 |
Beijing Beilu Pharmaceutical Co., Ltd Approves Cash Dividend on A Shares for the Year 2024, Payable on 19 May 2025
| | |
08/05/25 |
Beijing Beilu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 300 million in funding
| | |
24/04/25 |
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
18/04/25 |
Beijing Beilu Pharmaceutical Co., Ltd Proposes Final Cash Dividend for 2024
| | |
17/04/25 |
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
| | |
03/03/25 |
Sanxia Paints to Sell Stake in Beilu Pharma
| | |
13/01/25 |
Beijing Beilu Pharmaceutical Seeks Bank Loan with Subsidiary's Equity as Collateral
| | |
29/10/24 |
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
| | |
27/08/24 |
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2024
| | |
21/04/24 |
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
| | |
29/02/24 |
Beijing Beilu Pharmaceutical Co., Ltd Signed a Letter of intent to acquire 80% stake in Chengde Tianyuan Pharmaceuticals Co.,Ltd from Goldenmax International Group Ltd. for CNY 248 million.
| | |
26/10/23 |
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
| | |
27/08/23 |
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
| | |
18/05/23 |
Beijing Beilu Pharmaceutical Co., Ltd Announces Cash Dividend on A Shares for 2022, Payable on May 25, 2023
| | |
17/05/23 |
Beijing Beilu Pharmaceutical Co., Ltd Approves Cash Dividend for 2022
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
